ASEX
ILYDA
Market cap49mUSD
Nov 12, Last price
5.26EUR
Name
Ilyda SA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ilyda S.A. is a Greek software development firm specializing in a broad spectrum of business solutions. Its offerings include general enterprise resource planning (ERP) platforms such as MegaTron ERP and Kinitron Smart ERP. The company also tailors specialized systems for specific industries, providing the Dioscourides Smart, XPress, and Retail System ERPs for pharmacies, MegaTron Pharma ERP for drugstores, and the LIS Bio-Diagnosis system for microbiological laboratories. Furthermore, Ilyda develops targeted applications for public and utility sectors, including MegaTron DEVA for water supply and sewerage companies, PSIS Financial Management for public sector entities, PSIS Payroll & Personnel Management for legal organizations, and SIS Secretariats for educational institutions. Beyond software creation, the company offers extensive support services, encompassing telephone, remote, on-site, and feedback-based assistance, as well as project design and implementation, and comprehensive software training. Founded in 1992, Ilyda S.A. is headquartered in Athens, Greece.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||